On the path to TCR-directed therapeutics [4]

Nature Biotechnology

Volumn 24, Issue 6, 2006, Pages 615-616

  Laugel, Bruno ^a   Price, David A ^b   Sewell, Andrew K ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE; T LYMPHOCYTE RECEPTOR;

ALPHA CHAIN; BETA CHAIN; BIOTECHNOLOGY; CD8+ T LYMPHOCYTE; CELL LINE; CELL POPULATION; CELL SURFACE; CROSS REACTION; FLOW CYTOMETRY; LETTER; PRIORITY JOURNAL; RANDOMIZATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; ANTIGEN-ANTIBODY REACTIONS; CELLS, CULTURED; DIMERIZATION; FLUORESCENCE POLARIZATION IMMUNOASSAY; GENES, MHC CLASS I; MACACA MULATTA; MULTIPROTEIN COMPLEXES; PROTEIN BINDING; PROTEIN ENGINEERING; PROTEIN INTERACTION MAPPING; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 33745099609     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0606-615b     Document Type: Letter

References (11)

1. Mason, D. Immunol. Today 19, 395-404 (1998).
2. Laugel, B. et al. J. Biol. Chem. 280, 1882-1892 (2005).
3. Foote, J. & Eisen, H.N. Proc. Natl. Acad. Sci. USA 97, 10679-10681 (2000).
4. Holler, P.D. et al. Proc. Natl. Acad. Sci. USA 97, 5387-5392 (2000).
5. Kieke, M.C. et al. Proc. Natl. Acad. Sci. USA 96, 5651-5656 (1999).
6. Shusta, E.V., Holler, P.D., Kieke, M.C., Kranz, D.M. & Wittrup, K.D. Nat. Biotechnol. 18, 754-759 (2000).
7. Li, Y. et al. Nat. Biotechnol. 23, 349-354 (2005).
8. Molloy, P.E., Sewell, A.K. & Jakobsen, B.K. Curr. Opin. Pharmacol. 5, 438-443 (2005).
9. Chames, P., Hufton, S.E., Coulie, P.G., Uchanska-Ziegler, B. & Hoogenboom, H.R. Proc. Natl. Acad. Sci. USA 97, 7969-7974 (2000).
10. Denkberg, G. et al. Proc. Natl. Acad. Sci. USA 99, 9421-9426 (2002).
11. Hulsmeyer, M. et al. J. Biol. Chem. 280, 2972-2980 (2005).